Stocks News

LAST PRICE
93.1700
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
94.5300/ 1
Ask / Lots
118.4000/ 3
Open / Previous Close
--- / 93.1700
Day Range
---
52 Week Range
Low 56.6600
High 105.0000
Volume
209
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 13, 2024
- RBC Lifts Price Target on Axsome Therapeutics to $132 From $131, Keeps Outperform Rating, from 7:49AM ET on Wednesday Nov 13, 2024 by MT Newswires
  7:49AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: AXSM
  07:49 AM EST, 11/13/2024 (MT Newswires) -- Axsome Therapeutics (AXSM) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $105 to $180. (MT Newswires covers equity, commodity and economic rese...
- DJ Axsome Therapeutics Is Maintained at Outperform by Baird, from 7:28AM ET on Wednesday Nov 13, 2024 by Dow Jones
  7:28AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: AXSM
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AXSM/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 13, 2024 07:28 ET (12:28 GMT)
- DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 5:29AM ET on Wednesday Nov 13, 2024 by Dow Jones
  5:29AM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: AXSM
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AXSM/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 13, 2024 05:29 ET (10:29 GMT)
Nov 12, 2024
- Top Midday Gainers, from 12:09PM ET on Tuesday Nov 12, 2024 by MT Newswires
  12:09PM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: HON, RGEN, AXSM
  12:09 PM EST, 11/12/2024 (MT Newswires) -- Repligen (RGEN) shares added more than 5% after the medical device company reported higher Q3 adjusted earnings and revenue and also increased its 2024 guidance. Trading volume for Repligen shares has been ...
- Sector Update: Health Care Stocks Mixed Premarket Tuesday, from 9:10AM ET on Tuesday Nov 12, 2024 by MT Newswires
  9:10AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: IBB, RGEN, XLV, AZN, AXSM
  09:10 AM EST, 11/12/2024 (MT Newswires) -- Health care stocks were mixed premarket Tuesday as the iShares Biotechnology ETF (IBB) was 0.2% higher and the Health Care Select Sector SPDR Fund (XLV) was down 0.1% recently. Repligen (RGEN) shares were u...

Yesterday
- The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations, from 17 hours ago by Dow Jones
  17 hours ago by Dow Jones
  Companies Mentioned: ADMA
Nov 16, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 12:03PM ET on Saturday Nov 16, 2024 by Dow Jones
  12:03PM ET on Saturday Nov 16, 2024 by Dow Jones
  Companies Mentioned: ADMA
- ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm, from 11:46AM ET on Saturday Nov 16, 2024 by Dow Jones
  11:46AM ET on Saturday Nov 16, 2024 by Dow Jones
  Companies Mentioned: ADMA
Nov 15, 2024
- The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Violating Securities Laws, from 1:15PM ET on Friday Nov 15, 2024 by Dow Jones
  1:15PM ET on Friday Nov 15, 2024 by Dow Jones
  Companies Mentioned: ADMA
Nov 14, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 6:46PM ET on Thursday Nov 14, 2024 by Dow Jones
  6:46PM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: ADMA
- ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 11:48AM ET on Thursday Nov 14, 2024 by Dow Jones
  11:48AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: ADMA
- CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference, from 8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
  8:30AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: CRSP
Nov 13, 2024
- The Schall Law Firm Invites Shareholders To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations, from 1:01PM ET on Wednesday Nov 13, 2024 by Dow Jones
  1:01PM ET on Wednesday Nov 13, 2024 by Dow Jones
  Companies Mentioned: ADMA
- Arcellx Insider Sold Shares Worth $1,242,170, According to a Recent SEC Filing, from 3:22AM ET on Wednesday Nov 13, 2024 by MT Newswires
  3:22AM ET on Wednesday Nov 13, 2024 by MT Newswires
  Companies Mentioned: ACLX
Nov 12, 2024
- ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm, from 9:00PM ET on Tuesday Nov 12, 2024 by Dow Jones
  9:00PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: ADMA

Axsome Therapeutics Inc
NASDAQ:AXSMUnited States

Search Criteria

Nov 13, 2024

RBC Lifts Price Target on Axsome Therapeutics to $132 From $131, Keeps Outperform Rating, from 7:49AM ET on Wednesday Nov 13, 2024 by MT Newswires

DJ Axsome Therapeutics Is Maintained at Outperform by Baird, from 7:28AM ET on Wednesday Nov 13, 2024 by Dow Jones

DJ Axsome Therapeutics Price Target Maintained With a $130.00/Share by Needham, from 5:29AM ET on Wednesday Nov 13, 2024 by Dow Jones

Nov 12, 2024

Top Midday Gainers, from 12:09PM ET on Tuesday Nov 12, 2024 by MT Newswires

Sector Update: Health Care Stocks Mixed Premarket Tuesday, from 9:10AM ET on Tuesday Nov 12, 2024 by MT Newswires

Peers Headlines

Yesterday

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations, from 17 hours ago by Dow Jones

Nov 16, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 12:03PM ET on Saturday Nov 16, 2024 by Dow Jones

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Encouraged To Reach Out To The Schall Law Firm, from 11:46AM ET on Saturday Nov 16, 2024 by Dow Jones

Nov 15, 2024

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into ADMA Biologics Inc For Violating Securities Laws, from 1:15PM ET on Friday Nov 15, 2024 by Dow Jones

Nov 14, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 6:46PM ET on Thursday Nov 14, 2024 by Dow Jones

ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 11:48AM ET on Thursday Nov 14, 2024 by Dow Jones

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference, from 8:30AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 13, 2024

The Schall Law Firm Invites Shareholders To Join An Inquiry Into ADMA Biologics Inc For Securities Law Violations, from 1:01PM ET on Wednesday Nov 13, 2024 by Dow Jones

Arcellx Insider Sold Shares Worth $1,242,170, According to a Recent SEC Filing, from 3:22AM ET on Wednesday Nov 13, 2024 by MT Newswires

Nov 12, 2024

ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the Firm, from 9:00PM ET on Tuesday Nov 12, 2024 by Dow Jones